FACTANKER · measured, cited, anchored official records connected

ImmuCell Corporation — Operating Income by Fiscal Year

17 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/f25ea1d5-69f9-4684-8f91-b720788eaca3/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$1.6M2025-01-01 – 2025-12-31evidence 0001437749-26-010339
FY 2024$-1.6M2024-01-01 – 2024-12-31evidence 0001013762-25-004072
FY 2023$-5.7M2023-01-01 – 2023-12-31evidence 0001213900-24-028718
FY 2022$-2.3M2022-01-01 – 2022-12-31evidence 0001213900-23-024080
FY 2021$257.4k2021-01-01 – 2021-12-31evidence 0001213900-22-016147
FY 2020$-1.4M2020-01-01 – 2020-12-31evidence 0001213900-21-018473
FY 2019$-953.9k2019-01-01 – 2019-12-31evidence 0001213900-20-007650
FY 2018$-1.4M2018-01-01 – 2018-12-31evidence 0001213900-19-004653
FY 2017$-242.8k2017-01-01 – 2017-12-31evidence 0001213900-18-003621
FY 2016$890.2k2016-01-01 – 2016-12-31evidence 0001213900-17-003009
FY 2015$2.1M2015-01-01 – 2015-12-31evidence 0001213900-16-011870
FY 2014$-206.4k2014-01-01 – 2014-12-31evidence 0001213900-15-002097
FY 2013$-19.6k2013-01-01 – 2013-12-31evidence 0001144204-14-017813
FY 2012$245.0k2012-01-01 – 2012-12-31evidence 0001144204-13-018264
FY 2011$-632.7k2011-01-01 – 2011-12-31evidence 0001144204-12-017287
FY 2010$-690.3k2010-01-01 – 2010-12-31evidence 0001144204-12-017287
FY 2009$-529.9k2009-01-01 – 2009-12-31evidence 0001144204-12-017287
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

ImmuCell Corporation — all facts · Revenue · Net Income